A 65-year-old woman with a history of heart failure and atrial fibrillation is hospitalized for acute pyelonephritis. She is appropriately started on intravenous ciprofloxacin. Her home medications, including sotalol, are continued upon admission. On hospital day 2, she experiences a syncopal episode, and telemetry demonstrates a brief run of torsades de pointes. A 12-lead electrocardiogram reveals a QTc interval of 560 msec. She is successfully stabilized with intravenous magnesium sulfate. A subsequent review of the event reveals that the electronic health record (EHR) generated a drug-drug interaction warning when the ciprofloxacin was ordered. However, the admitting physician bypassed the warning because similar alerts frequently trigger for clinically insignificant interactions. A multidisciplinary quality improvement committee is convened to perform a root cause analysis and identifies alert fatigue as the primary contributing factor. Based on the hierarchy of intervention reliability, which of the following is the most appropriate action by the committee to prevent similar adverse events?
- Integrate an electronic forcing function that prevents finalizing the order for severe QTc-prolonging agent combinations without electrophysiology approvalCevap
- BDistribute a laminated reference card to all clinicians detailing high-risk QTc-prolonging medication combinations
- CRevoke the prescribing privileges of the physician who bypassed the alert until remedial pharmacology training is completed
- DDefer disclosing the medication error to the patient until the hospital confirms no permanent myocardial damage has occurred
- ESend a weekly automated email report to department chairs detailing which physicians have the highest alert override rates